http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3149702-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f780c6fdbb463e17a8c7c0c069ac3c42
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2020-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_735f998486c16078ef8cbd2a4f5bb297
publicationDate 2021-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3149702-A1
titleOfInvention Treatment of fragile x syndrome
abstract The present invention relates to a composition comprising ibudilast, or a pharmaceutically acceptable salt thereof, for use in the treatment of Fragile X syndrome, wherein the composition does not comprise sulindac, or a pharmaceutically acceptable salt thereof, or bumetanide, or a pharmaceutically acceptable salt thereof.
priorityDate 2019-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454185321
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108684022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421072000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6558
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22483
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480424
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20496
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID106478973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505573
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20498
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1023
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6557
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID735034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546552
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457460012
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373706

Total number of triples: 43.